Details
New companies 3 · Follow-on 0
Stages: Seed 2, Pre-seed 1
Polygrade $6.3M SeedCharter Space $5M SeedO-ID $1M Pre-seedRanked by rounds participated in, from announcements in Sep 18, 2026 – Oct 17, 2026. Lead counts include only confirmed lead roles.
New companies 3 · Follow-on 0
Stages: Seed 2, Pre-seed 1
Polygrade $6.3M SeedCharter Space $5M SeedO-ID $1M Pre-seedNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1, Series B 1
Autopoiesis Sciences $11M SeedSplit Pay ~$100M Series BSplit Pay $25M Series ANew companies 2 · Follow-on 1
Stages: Series B 1, Series C+ 1, Undisclosed 1
Savvy Wealth $100M Series CMona $3.5M Oversubscribed roundFootprint $25M Series BNew companies 2 · Follow-on 1
Stages: Series C+ 2, Seed 1
Furientis $25M SeedInstinct $1B Series CNumeral $100M Series CNew companies 3 · Follow-on 0
Stages: Series B 2, Seed 1
General Medicine $120M Series BCorridor $25M SeedFootprint $25M Series BNew companies 3 · Follow-on 0
Stages: Series A 2, Series C+ 1
Melius $20M Series AJeeves $110M Series C-1Raindrop Undisclosed Series ANew companies 3 · Follow-on 0
Stages: Pre-seed 1, Seed 1, Series A 1
Minerva Humanoids Undisclosed Pre-SeedOuterSignal $22M Series ASnag $4M SeedNew companies 3 · Follow-on 0
Stages: Series B 2, Series A 1
Spiko $90M Series BNamespace $42M Series BBasalt Health $20M Series ANew companies 3 · Follow-on 0
Stages: Pre-seed 1, Seed 1, Undisclosed 1
hexafarms €4.8M SeedLocus Lock Undisclosed Strategic fundingO-ID $1M Pre-seedNew companies 2 · Follow-on 1
Stages: Series A 2, Undisclosed 1
Flai $27M Series AEfficient Computer $100M Additional fundingHertha Metals $133.7M Series ANew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Series B 1
Namespace $42M Series BVolantis $88M Series AEuka AI $5M SeedNew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Undisclosed 1
Hestus, Inc. $7.4M SeedDaedal Systems $4M FundingAstrus $12M Series ANew companies 2 · Follow-on 1
Stages: Seed 1, Series B 1, Undisclosed 1
Armadin $255.5M Series BLocus Lock Undisclosed Strategic fundingTERASi €11M SeedNew companies 3 · Follow-on 0
Stages: Series A 1, Series B 1, Undisclosed 1
Miter $40M Series BFeldera $15.4M Series APhigenics Undisclosed InvestmentNew companies 3 · Follow-on 0
Stages: Seed 1, Series B 1, Undisclosed 1
Charter Space $5M SeedTiny Health $33M Series BMoneyStack $1M UndisclosedNew companies 3 · Follow-on 0
Stages: Seed 2, Series A 1
Aptadir Therapeutics €40M SeedClastix €2.9M SeedTundr €11.6M Series ANew companies 3 · Follow-on 0
Stages: Seed 1, Series C+ 1, Undisclosed 1
SiMa.ai $150M Series CSolcoa Industries $75M Seed financing; equity, debt, and equipment financingBird $450M Debt financingNew companies 3 · Follow-on 0
Stages: Series C+ 3
BigHat Biosciences $75M Series CBasecamp Research $140M Series CEnveda $311M Series ENew companies 3 · Follow-on 0
Stages: Undisclosed 2, Series B 1
Reactive Technologies €19M EIB venture debtMorphotonics >€40M Series BHighLife €80M Financing roundNew companies 3 · Follow-on 0
Stages: Series C+ 2, Series B 1
Ema $77M Series BBasecamp Research $140M Series CSnorkel AI $350M Series ENew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Undisclosed 1
Spott $21M Series AUnit1 Studio £20M Equity round and production financingMantic $25M SeedNew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Estuary Biotherapeutics $93M Series AAptadir Therapeutics €40M SeedNew companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
RapidCanvas $29M Series BMeantToBe, Inc. $10.5M SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Beff Inc. ~¥300M Series A final closeQBITech Co., Ltd. ~¥600M Series BNew companies 2 · Follow-on 0
Stages: Series A 2
Estuary Biotherapeutics $93M Series Aai3Bio $48M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Abby Care $82M Series CBasalt Health $20M Series ANew companies 2 · Follow-on 0
Stages: Pre-seed 1, Series C+ 1
Solvera $6.3M Pre-seedBasecamp Research $140M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Origin Undisclosed UndisclosedKheops €12M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
OMass Therapeutics $310M Series CSoufflé Therapeutics $135M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
OMass Therapeutics $310M Series CAnaCardio €62.5M Series B“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.